ABSTRACT NUMBER: ESOC2026A1917 INFLUENCE OF INFARCT VOLUME ON CIRCULATING INFLAMMATORY MARKER LEVELS AFTER ACUTE ISCHEMIC STROKE AND TIA

Abstract Background and aims Routine measurement of circulating inflammatory markers after ischemic stroke/TIA identifies patients at risk of recurrence and could guide patient selection for anti-inflammatory therapies for prevention. However, the influence of brain infarction on circulating markers is poorly understood and the optimal timing of measurement for risk prediction is unknown. Methods We performed a prospective multi-centred cohort study which included patients with recent (0-14 days) non-severe ischemic stroke (mRS≤3) or TIA. We measured MCP-1, IL-6, IL-8, IL-10, IL-12, hsCRP and TNFa and measured infarct volume using manual quantification on DWI sequence. We performed multivariate linear regression to explore the relationship between inflammatory markers and infarct volume after adjustment for confounding factors. Results MRI and inflammatory marker data was available for 365 patients; median infarct volume 0.81cm3 (IQR 0.29 – 3.68cm3) median time to phlebotomy 48hrs (IQR 25-73hrs), 74% non-severe stroke/26% TIA. Following adjustment for age, sex, cholesterol, smoking and atrial fibrillation, infarct volume was modestly associated with IL-6 (ß 0.0084, 95% CI -0.0002 – 0.017) (Figure 1). HsCRP was not associated with infarct volume (ß 0.011, 95% CI -0.0035 – 0.025) (Figure 2). No association was found for the other markers analysed. Conclusions Our findings demonstrate that infarct volume has a modest, clinically insignificant effect on circulating IL-6 in the days following a non-severe stroke/TIA, with no effect on the remaining inflammatory markers analysed. These data suggest that inflammatory marker measurement for risk stratification and patient selection for anti-inflammatory prevention strategies should be performed approximately 24hours after stroke. Conflict of interest Jane Buckley: nothing to disclose Figure 1 - belongs to Methods Figure 2 - belongs to Results

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.903
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1917 INFLUENCE OF INFARCT VOLUME ON CIRCULATING INFLAMMATORY MARKER LEVELS AFTER ACUTE ISCHEMIC STROKE AND TIA

Tim Cassidy, Joseph Harbison, Michael Marnane, Jane Buckley et al.
European Stroke Journal
Neuroinflammation and Neurodegeneration Mechanisms
article

ABSTRACT NUMBER: ESOC2026A1917 INFLUENCE OF INFARCT VOLUME ON CIRCULATING INFLAMMATORY MARKER LEVELS AFTER ACUTE ISCHEMIC STROKE AND TIA

Tim Cassidy, Joseph Harbison, Michael Marnane, Jane Buckley, D Williams, John McCabe, Peter Kelly, Orina Belton, Eamon Dolan, Jonathan McNulty
article en

Abstract

Abstract Background and aims Routine measurement of circulating inflammatory markers after ischemic stroke/TIA identifies patients at risk of recurrence and could guide patient selection for anti-inflammatory therapies for prevention. However, the influence of brain infarction on circulating markers is poorly understood and the optimal timing of measurement for risk prediction is unknown. Methods We performed a prospective multi-centred cohort study which included patients with recent (0-14 days) non-severe ischemic stroke (mRS≤3) or TIA. We measured MCP-1, IL-6, IL-8, IL-10, IL-12, hsCRP and TNFa and measured infarct volume using manual quantification on DWI sequence. We performed multivariate linear regression to explore the relationship between inflammatory markers and infarct volume after adjustment for confounding factors. Results MRI and inflammatory marker data was available for 365 patients; median infarct volume 0.81cm3 (IQR 0.29 – 3.68cm3) median time to phlebotomy 48hrs (IQR 25-73hrs), 74% non-severe stroke/26% TIA. Following adjustment for age, sex, cholesterol, smoking and atrial fibrillation, infarct volume was modestly associated with IL-6 (ß 0.0084, 95% CI -0.0002 – 0.017) (Figure 1). HsCRP was not associated with infarct volume (ß 0.011, 95% CI -0.0035 – 0.025) (Figure 2). No association was found for the other markers analysed. Conclusions Our findings demonstrate that infarct volume has a modest, clinically insignificant effect on circulating IL-6 in the days following a non-severe stroke/TIA, with no effect on the remaining inflammatory markers analysed. These data suggest that inflammatory marker measurement for risk stratification and patient selection for anti-inflammatory prevention strategies should be performed approximately 24hours after stroke. Conflict of interest Jane Buckley: nothing to disclose Figure 1 - belongs to Methods Figure 2 - belongs to Results

European Stroke JournalVol. 11(Supplement_1)
University College Dublin (IE), Mercer (Czechia) (CZ), Royal College of Surgeons in Ireland (IE), Connolly Hospital Blanchardstown (IE), Beaumont Hospital (IE), Mater Misericordiae University Hospital (IE), Health Research Board (IE), St. Vincent's University Hospital (IE)
Good health and well-being
Openalex Percentile: Top 9%
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.